research

Dear Research Advocate: As I write, most members of Congress are on the way home for August recess. As anticipated, no further action has been taken on the appropriations front ’€“ or much else, for that matter. In terms of issues we care about: no movement on tax reform, which means no much-needed enhancement of the research and development tax credit; no repeal of the medical device tax; and no final passage of Fiscal Year 2015 appropriations bills. In upcoming letters I will talk in more detail about Capitol Hill-focused advocacy strategies through the election and beyond. In the absence of legislative action, some attention ’€“ in a bipartisan manner ’€“ is being given to research for...
Research!America applauds Senator Tom Harkin for taking bold, decisive action to heal fissures in our nation’€™s research pipeline with legislation that will strengthen the National Institutes of Health (NIH) budget over the next six years. The Accelerate Biomedical Research Act will establish a pathway for sustained growth in the NIH budget. That budget has remained virtually stagnant over the last decade, jeopardizing promising research to combat disease and deflating the aspirations of early career scientists. NIH-funded research fuels the development of lifesaving therapies and treatments, and creates opportunities for public-private partnerships to better understand Alzheimer’€™s,...
Excerpt of an op-ed by Society for Neuroscience Early Career Science Policy Fellow Matthew J. Robson, PhD, published in The Tennessean . The United States has historically been a consistent, international force of innovation and advancement in biomedical research. Such research is not possible without federal funding of the National Institutes of Health (NIH), an agency within the Department of Health and Human Services. Although the NIH supports basic biomedical research aimed at a greater understanding of the causes of disease and the improved health of all Americans, relatively few understand the scope of the accomplishments of this agency. Research that depends upon NIH funding has...
Dear Research Advocate: My colleagues at Research!America have shared the role as author of our weekly letter during my recent sabbatical. My thanks to them for providing timely and actionable information to our wide network. As I am ’€œre-entering’€ the Washington space, I have been struck by (1) the significantly worse condition of the roads ’€” potholes everywhere, and now even sinkholes in DC! I’€™ve been in several global capitals this spring, including in less-developed countries, and DC doesn’€™t look good in comparison. Via recent domestic travels, I can attest to the poor condition of our roads nationwide, taking a toll on vehicles and our economy, while eroding public confidence...
By Mark A. Reynolds, DDS, PhD, MA, dean of the University of Maryland School of Dentistry The University of Maryland School of Dentistry (UMSOD) is the world’€™s first dental school, founded in 1840 in Baltimore, Maryland. The school has a distinguished history of graduating exceptional dentists and dental hygienists who advance the oral and overall health of patients in Maryland and around the world. Researchers at the School of Dentistry are dedicated to discovering and developing new treatments for diseases. Our scientists are leaders in the fields of oncology, pain and neuroscience, and microbial pathogenesis. UMSOD recognizes that training dental scientists is essential to improve the...
Dear Research Advocate: This week, the research advocacy community suffered a tremendous loss. John Rehm , husband of Diane Rehm, passed away Monday. Diane, the host of The Diane Rehm Show on NPR, was honored by Research!America last year for her advocacy with the Isadore Rosenfeld Award for Impact on Public Opinion . Her late husband was a friend and longtime supporter of the Parkinson’€™s disease community. Our thoughts are with the Rehm family during this difficult time. As you pursue your advocacy efforts, we hope the newest fact sheet in our series about the human impact of research will prove useful. Max Hasenauer was diagnosed at 22-months-old with X-linked Agammaglobulinemia (XLA)...
By Peter W. Kalivas, PhD, President of the American College of Neuropsychopharmacology. Dr. Kalivas is Professor and Chair, Department of Neurosciences at the Medical University of South Carolina. The American College of Neuropsychopharmacology (ACNP), founded in 1961, is the nation’s premier professional society in brain, behavior, and neuropharmacology research. The field of neuropsychopharmacology involves evaluating the effects of natural and synthetic compounds upon the brain, mind, and human behavior, and the ACNP serves as a forum for advancing the latest discoveries about the brain towards cures for neuropsychiatric diseases. The core purpose of the ACNP is to catalyze and advance...
By Ellen L. Woods, President of the American Foundation for Pharmaceutical Education The American Foundation for Pharmaceutical Education (AFPE) is a national nonprofit organization located in Arlington, VA. AFPE was founded in 1942 and is the oldest pharmacy foundation in the nation. Now for more than 70 years, AFPE has provided fellowships, scholarships and grants to help educate thousands of the very best and brightest students in the pharmaceutical sciences in preparation for distinguished careers. AFPE fellows engage in important, cutting-edge drug research that affects health outcomes in areas across the spectrum, from diabetes, heart disease, cancer, obesity, Alzheimer’€™s and other...
By Bill Leinweber, President of the National Disease Research Interchange The National Disease Research Interchange (NDRI) is a 501 (c)(3) national organization based in Philadelphia. NDRI is a national leader in the procurement and distribution of human organs, cells and tissues to support the advancement of medical and health research. The NIH has provided funding to NDRI since 1987, and the organization serves over 100 corporate partners. Researchers in academic medical centers, nonprofit research organizations, as well as pharmaceutical, biotechnology and medical device companies rely on NDRI for access to quality human biospecimens and data. NDRI distributes more than 20,000...
Research!America members and partners extend warm congratulations to Research!America Chair The Honorable John Edward Porter for his well-deserved recognition by the National Institutes of Health (NIH) with the dedication of the Porter Neuroscience Research Center. Our nation has benefited from Mr. Porter’s leadership in advancing medical and health research as chair of the House Appropriations Subcommittee on Labor, Health and Human Services, and Education during his tenure in Congress, and as an indomitable force in the research advocacy community. As a U.S. representative, he worked across the aisle to cultivate champions for research, articulating the societal and economic benefits of...

Pages

Sidebar Quote

Public sentiment is everything. With public sentiment, nothing can fail; without it nothing can succeed.
Abraham Lincoln